Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Nelson Syndrome × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7930 Neoplasms 5511 Prostatic Neoplasms 3719 Colorectal Neoplasms 3312 Lung Neoplasms 3005 Carcinoma, Non-Small-Cell Lung 2966 Pancreatic Neoplasms 2093 Carcinoma, Hepatocellular 2003 Leukemia, Myeloid, Acute 1873 Multiple Myeloma 1789 Stomach Neoplasms 1769 Neoplasm Metastasis 1595 Head and Neck Neoplasms 1551 Ovarian Neoplasms 1494 Brain Neoplasms 1452 Lymphoma 1439 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1431 Rectal Neoplasms 1403 Melanoma 1381 Colonic Neoplasms 1345 Leukemia 1257 Recurrence 1232 Uterine Cervical Neoplasms 1229 Glioblastoma 1112 Esophageal Neoplasms 1110 Lymphoma, Non-Hodgkin 999 Leukemia, Lymphocytic, Chronic, B-Cell 928 Urinary Bladder Neoplasms 912 Squamous Cell Carcinoma of Head and Neck 909 Lymphoma, Large B-Cell, Diffuse 873

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01617733 2016-11-02

Pasireotide Therapy in Patients With Nelson's Syndrome

Sheffield Teaching Hospitals NHS Foundation Trust

Phase 2 Terminated

Nelson Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡